Skip to content
AdminOct 27, 2021< 1 min read

Synthetic Data Generation for Rare Disease Research

2021-10-27-Synthetic-Data-Generation-for-Rare-Disease-Research-1

Khaled El Emam, CEO, Replica Analytics, Jason Colquitt, CEO Across Healthcare

This webinar, presented by Dr. Khaled El Emam and Jason Colquitt, discusses the small data challenges of rare disease research and how synthetic data generation can help address these challenges.

 

 

Following the acquisition of Replica Analytics by Aetion, the generative AI technology previously known as Replica Synthesis is now Aetion® Generate and continues to create privacy-enhancing synthetic data.
Learn More

RELATED ARTICLES

AdminMay 6, 20241 min read

Navigating the European Union's Medical Device Regulation (MDR)

On May 26, 2021 the European Union’s (EU) Medical Device Regulation (MDR) became effective. The MDR overhauls how the EU ...
Start Reading
Xi FangApr 20, 20241 min read

How to unleash the replicability potential of synthetic data

In today's data-driven world, the need for innovative solutions to evolve alongside the ever-challenging landscape of privacy ...
Start Reading
AdminApr 19, 2024< 1 min read

Case Study: Enhancing clinical trial data sharing with synthetic datasets

Unlock the future of research with our groundbreaking approach to privacy-preserving data sharing. Our case study, "Enhancing ...
Start Reading